Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ · Healthcare
Acadia Pharmaceuticals Inc. Shares Outstanding 2009–2025
Acadia Pharmaceuticals Inc. annual/quarterly shares outstanding history and growth rate from 2009 to 2026. Shares outstanding refers to a company's stock currently held by all its shareholders, including institutional investors and company insiders.
- Acadia Pharmaceuticals Inc. shares outstanding for the quarter ending March 31, 2026 was 0.17 B shs, a 3.00% increase year-over-year.
- Acadia Pharmaceuticals Inc. annual shares outstanding for 2025 was 0.17 B shs, a 2.14% increase from 2024.
- Acadia Pharmaceuticals Inc. annual shares outstanding for 2024 was 0.17 B shs, a 1.55% increase from 2023.
- Acadia Pharmaceuticals Inc. annual shares outstanding for 2023 was 0.16 B shs, a 1.32% increase from 2022.
- Acadia Pharmaceuticals Inc. annual shares outstanding for 2022 was 0.16 B shs.
Shares Outstanding
ANNUAL · B SHS
QUARTERLY · B SHS
YEAR-OVER-YEAR GROWTH · %
Acadia Pharmaceuticals Inc. Shares Outstanding — FAQ
Acadia Pharmaceuticals Inc. (ACAD) shares outstanding over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Acadia Pharmaceuticals Inc.'s shares outstanding?
Acadia Pharmaceuticals Inc. (ACAD) reported shares outstanding of 0.17B shares for fiscal 2025.
Where can I see ACAD's shares outstanding history?
The chart and table above show Acadia Pharmaceuticals Inc.'s shares outstanding by year and by quarter, including the growth rate.